| The clinical effect of the treatment of chronic glomerulonephritis with Tongxin Luo capsule was observed and was compared with the effect of the treatment with angiotensin converting enzyme inhibitor (ACEI). The result shows: in group that patients was treated with Tongxin Luo capsule, the major symptoms of the patients such as oedema, lethargy, aching in back, dark and gloomy face were relieved or disappeared. Proteinuria and hematuria were reduced. Blood viscosity, plasma viscosity, erythrocyte deformed index, fibrinogen and Plt were decreased. APTT and PT were prolonged. FDP in blood and urine of partly patients became negative from positive.TC, TG, LDL-C, APO-B, and LP (a) were decreased. Scr and BUN were decreased. IgG was increased. The studied results point out that Tongxin Luo capsule can raise immune function, and improve the symptoms, and improve hyperviscositimia and hypercoagulate state, and decrease blood lipids, and reduce proteinuria, and protect the kidney function of the patients with chronic glomerulonephritis. The total clinical efficiency in the group of Tongxin Luo capsule is 83.3%. the difference of Statistics between the efficiency of the two groups is not notable(P>0.05). the possible mechanisms of efficiency of the treatment of chronic glomerulonephritis with Tongxin Luo capsule are studied theoretically in the final part of the thesis.
|
PDF Full Text Request